Skip to main content
Ferozsons Laboratories Limited logo

Ferozsons Laboratories Limited — Investor Relations & Filings

Ticker · FEROZ ISIN · PK0005201014 PSX Manufacturing
Open in API
Filings indexed 155 across all filing types
Latest filing 2026-04-30 Interim / Quarterly Rep…
Country PK Pakistan
Listing PSX FEROZ

About Ferozsons Laboratories Limited

https://ferozsons-labs.com/

Ferozsons Laboratories Limited is a pharmaceutical company engaged in the import, manufacturing, and sale of pharmaceutical products and medical devices. It is recognized as a leading provider of treatments, notably in Hepatology. The company maintains exclusive agreements with international partners for distribution, selling, and co-marketing. Its product portfolio encompasses Pharma & OTC products and Medical Technologies, serving patients and physicians, with an emphasis on exports.

Recent filings

Filing Released Lang Actions
Transmission of Quarterly Report for the Period Ended 31-03-2026
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Financial Information For The Nine Months Ended 31 March 2026' and contains detailed financial statements including statements of financial position, profit or loss, comprehensive income, changes in equity, cash flows, and notes for both standalone and consolidated figures. It includes a Directors' Review Report on the condensed interim financial information, financial highlights, operational review, and subsidiary performance. The document covers a period shorter than a full fiscal year (nine months) and contains substantive financial data and analysis. The length of the document (15,000 characters) and the detailed financial content confirm it is a full interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2026
2026-04-30 English
Financial Results for the Quarter Ended 31-03-2026
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial statements including a Condensed Interim Unconsolidated Statement of Financial Position, Statement of Profit or Loss, Statement of Comprehensive Income, Statement of Changes in Equity, and Statement of Cash Flows for the nine months and quarter ended 31 March 2026. The presence of actual financial data, including revenues, expenses, profits, equity changes, and cash flows, indicates this is a comprehensive financial report for a period shorter than a full fiscal year. The term 'Condensed Interim' and the reporting period (nine months and quarter ended 31 March 2026) clearly identify this as an interim or quarterly report rather than a full annual report or an earnings release. The document is also quite lengthy (15,000 characters), so it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-04-29 English
Transmission of Quarterly Financial Statements for the Period Ended 31-12-2025
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Interim Financial Information For The Half Year Ended 31 December 2025' and contains detailed financial statements including statements of financial position, profit or loss, comprehensive income, changes in equity, cash flows, and notes for both standalone and consolidated entities. It includes a Directors' Review Report, an Independent Auditor's Review Report, and detailed financial and operational review sections. The document covers a half-year period ending 31 December 2025, which is a period shorter than a full fiscal year. The presence of substantive financial data and analysis confirms it is a financial report rather than an announcement or certification. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2026-02-27 English
Financial Results for the Quarter Ended 31-12-2025
Regulatory Filings
2026-02-26 English
Corporate Briefing Session - Presentation
Regulatory Filings
2025-11-20 English
Corporate Briefing Session
Regulatory Filings
2025-11-18 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.